VEXAS syndrome: a diagnostic puzzle
Open Access
Abstract
The VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is an adult-onset systemic autoinflammatory condition that is caused by an acquired deficiency of the UBA1 gene in hematopoietic progenitor cells. The clinical spectrum of the VEXAS syndrome currently comprises a broad range of phenotypes such as vasculitis, relapsing polychondritis and Sweet’s syndrome. In the past, VEXAS patients have left clinicians puzzled and the true nature of this disease has not been captured until late 2020. This viewpoint describes the relevant clinical features of the VEXAS syndrome and reviews different approaches to establish the diagnosis. Finally, future directions within the field of systemic inflammatory diseases caused by somatic mutations are being discussed.Keywords
This publication has 33 references indexed in Scilit:
- VEXAS Syndrome: A Case Series From a Single‐Center Cohort of Italian Patients With VasculitisArthritis & Rheumatology, 2021
- UBA1 Variations in Neutrophilic Dermatosis Skin Lesions of Patients With VEXAS SyndromeJAMA Dermatology, 2021
- Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1Blood Advances, 2021
- A Case of VEXAS Syndrome Complicated by Hemophagocytic LymphohistiocytosisJournal of Clinical Immunology, 2021
- Somatic Mutation in UBA1 and ANCA-associated VasculitisThe Journal of Rheumatology, 2021
- Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXASArthritis & Rheumatology, 2021
- Vacuolization of hematopoietic precursors: an enigma with multiple etiologiesBlood, 2021
- Hiding in Plain Sight — Somatic Mutation in Human DiseaseNew England Journal of Medicine, 2020
- Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory DiseaseNew England Journal of Medicine, 2020
- Relapsing polychondritis: state of the art on clinical practice guidelinesRMD Open, 2018